Relay Therapeutics Stock Price on July 31, 2024
| RLAY Stock | USD 6.20 0.06 0.98% |
Below is the normalized historical share price chart for Relay Therapeutics extending back to July 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Relay Therapeutics stands at 6.20, as last reported on the 11th of November 2024, with the highest price reaching 6.31 and the lowest price hitting 6.06 during the day.
If you're considering investing in Relay Stock, it is important to understand the factors that can impact its price. At this stage we consider Relay Stock to be moderately volatile. Relay Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0193, which implies the firm had a 0.0193% return per unit of risk over the last 3 months. We have found thirty technical indicators for Relay Therapeutics, which you can use to evaluate the volatility of the company. Please check Relay Therapeutics' Semi Deviation of 3.98, risk adjusted performance of 0.018, and Coefficient Of Variation of 8453.33 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%.
At this time, Relay Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 90.3 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 563.2 M in 2024. . Price To Sales Ratio is likely to drop to 50.19 in 2024. Price Earnings Ratio is likely to drop to -4.14 in 2024. Relay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of July 2020 | 200 Day MA 7.5037 | 50 Day MA 6.788 | Beta 1.675 |
Relay |
Sharpe Ratio = 0.0193
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | RLAY |
| Negative Returns |
Estimated Market Risk
| 7.65 actual daily | 68 68% of assets are less volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Relay Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Relay Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.4894 | Enterprise Value Ebitda (0.80) | Price Sales 28.8395 | Shares Float 127 M | Wall Street Target Price 22 |
Relay Therapeutics Main Headline on 31st of July 2024
Disposition of 13708 shares by Peter Rahmer of Relay Therape... by Peter Rahmer
Filed transaction by Relay Therapeutics Officer: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Relay Therapeutics Valuation on July 31, 2024
It is possible to determine the worth of Relay Therapeutics on a given historical date. On July 31, 2024 Relay was worth 8.3 at the beginning of the trading date compared to the closed value of 8.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Relay Therapeutics stock. Still, in general, we apply an absolute valuation method to find Relay Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Relay Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Relay Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 8.09 | 8.47 | 8.09 | 8.27 | 776,740 | |
07/31/2024 | 8.30 | 8.66 | 7.95 | 8.22 | 919,058 |
| 8.15 | 8.31 | 7.87 | 7.99 | 1,102,117 |
| Backtest Relay Therapeutics | | | Relay Therapeutics History | | | Relay Therapeutics Valuation | Previous | Next |
Relay Therapeutics Trading Date Momentum on July 31, 2024
| On August 01 2024 Relay Therapeutics was traded for 7.99 at the closing time. The top price for the day was 8.31 and the lowest listed price was 7.87 . The trading volume for the day was 1.1 M. The trading history from August 1, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.80% . The trading delta at closing time against the current closing price is 18.13% . |
Relay Therapeutics Fundamentals Correlations and Trends
By evaluating Relay Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Relay Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Relay financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Relay Therapeutics Stock history
Relay Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Relay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Relay Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Relay Therapeutics stock prices may prove useful in developing a viable investing in Relay Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 122.6 M | 69.5 M | |
| Net Loss | -261.5 M | -274.5 M |
Relay Therapeutics Quarterly Net Working Capital |
|
Relay Therapeutics Stock Technical Analysis
Relay Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Relay Therapeutics Period Price Range
Low | November 11, 2024
| High |
0.00 | 0.00 |
Relay Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Relay Therapeutics November 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Relay Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relay Therapeutics shares will generate the highest return on investment. By undertsting and applying Relay Therapeutics stock market strength indicators, traders can identify Relay Therapeutics entry and exit signals to maximize returns
Relay Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Relay Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Relay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Relay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.018 | |||
| Jensen Alpha | (0.55) | |||
| Total Risk Alpha | (1.49) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.02 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Relay Stock Analysis
When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.